Growth Hormone

Selective ghrelin-receptor agonist studied for pulsatile GH release with minimal off-target activity.

2mg · 5mg · 10mg

Stabilised GHRH analogue studied for visceral fat reduction and GH-axis restoration.

2mg · 5mg · 10mg

Soluble ActRIIB decoy receptor studied for binding myostatin and related ligands.

1mg

Locally-acting follistatin-based fusion protein studied for site-specific muscle growth.

1mg

Long-acting GHRH analogue whose drug-affinity complex extends half-life to days in research models.

2mg · 5mg · 10mg

Short-acting GHRH analogue studied for physiological GH pulse amplification.

2mg · 5mg · 10mg

Activin-binding protein studied as a myostatin antagonist in muscle research.

1mg

Myostatin-pathway research compound studied in muscle-growth regulation.

1mg

Myostatin protein used as a reference in muscle-signalling research.

1mg

Growth-hormone-releasing peptide studied for strong GH secretion with some appetite signalling.

2mg · 5mg · 10mg

First-generation GHRP studied for GH release and pronounced ghrelin-like appetite effects.

5mg · 10mg · 20mg

Recombinant human growth hormone, the reference compound of GH research.

10iu

Potent GHRP analogue studied for GH release and cardioprotective signalling.

2mg · 5mg · 10mg

Truncated IGF-1 variant studied for potent, short-lived local growth signalling.

1mg

Extended IGF-1 analogue with reduced binding-protein affinity, studied for growth signalling.

1mg

Modified GRF(1-29) tetra-substituted GHRH fragment studied alongside GHRPs.

2mg · 5mg

GHRH(1-29) analogue with a long clinical research history in GH-axis studies.

2mg · 5mg · 10mg